Home Exhibitions PPMA Show 2023 and Alimentaria FoodTech start tomorrow!

.news

PPMA Show 2023 and Alimentaria FoodTech start tomorrow!

📢 PPMA Show 2023 and Alimentaria FoodTech start tomorrow!

🔥 Join us as we present the PERFITHERM Skid! This cutting-edge unit combines the power of the PERFITHERM Scraped Surface Heat Exchanger model 5 with a state-of-the-art cooling setup with all the necessary controls and regulations. It’s designed to be plug-and-play, ready to revolutionize your operations.

⚙️ With a generous exchange surface of 0.5m², the PFTM5 model is perfect for a wide range of cooling applications involving viscous products. It’s the ultimate solution to optimize your processes and achieve exceptional results.

👀 Don’t miss out! Make sure to visit Holmach Ltd’s booth at PPMA Group of Associations and experience the future of heat exchange technology firsthand at the NEC in Birmingham from 26-28 September. | Make sure to visit RAIMABER FLUID TECH SL’s booth at Alimentaria FoodTech and experience the future of heat exchange technology firsthand at the Recinto Gran Via in Barcelona from 26-29 September.

🤝 We can’t wait to see you there and discuss how our PERFITHERM Skid can elevate your business to new heights. See you soon!

On Key

Related Posts

Looking Back at interpack 2026

Looking Back at interpack 2026: Process Engineering for the Future of Food Production Interpack 2026 once again brought together the global processing and packaging industry

LET'S COLLABORATE

READY TO WORK WITH US?

CONTACT US

Z. Ind. Lameiradas, lote 1 Mansores - 4540-423 Arouca, Portugal

perfinox@perfinox.pt

National landline call

International calls

OUR SERVICES
SUBSCRIBE

.there are no limits for process improvement

© Copyright 2025, PERFINOX S.A. 

BAIXAR brochura centro tecnológico

Por favor, preencha o formulário com os seus dados para aceder às especificações técnicas completas e às funcionalidades de teste.

Download our tech center brochure

Please, fill in your details to access the full technical specifications and trial capabilities.